• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • KTO
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • SGSC Global Bootcamp 2021
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • SGSC Demo Day
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • register
  • login
KoreaTechDesk
No Result
View All Result
KoreaTechDesk
No Result
View All Result
Home Health & Bio

BioMe Inc. & Yonsei Medical Center sign technology transfer contract for pathbreaking microbiome treatment

KoreaTechDesk Writer by KoreaTechDesk Writer
December 30, 2021
in Health & Bio
0
BioMe is working on microbe therapeutics.

BioMe is working on microbe therapeutics.

0
SHARES
145
VIEWS
Share on FacebookShare on Twitter

The microbiome treatment market is receiving global attention and is rapidly emerging as a new treatment alternative for various intractable diseases. However, recent clinical trial failure reports and the limitation to identify a clear mode of action demand a careful approach. Korea-based company BioMe Inc. wants to bring in disruption with pathbreaking microbiome-based therapeutics. 

Established in November 2020 by Professor Sang Sun Yoon of the Department of Microbiology and Immunology, Yonsei University College of Medicine, BioMe Inc. has been developing a microbiome-based live biotherapeutic product (LBP). Based on the distinguished microbiology research foundation of Yonsei University College of Medicine, BioMe Inc. 

(i) understands the bacteriological characteristics of the candidate strains, 

(ii) can prove its effectiveness using animal disease models, made possible in the state-of-the-art Avison Biomedical Research Centre.

To accelerate its research & development process, the startup recently signed a technology transfer contract with Yonsei University College of Medicine. BioMe Inc. would start developing microbiome-based therapeutics with the six patents transferred from Yonsei University College of Medicine.

The technology transfer under the contract includes a total of six patents, and BioMe’s development pipeline is as follows: 

No. Development Pipeline
1 A protein derived from airway microbiome with inhibitory effects against broad-spectrum respiratory infections
2 A microbiome-derived immune enhancing protein with clear anti-cancer effect
3 A skin microbiome showing efficacy in treating atopic dermatitis
4 A consortium of commensal microbes showing efficacy in treating inflammatory bowel disease
5 Novel synbiotics system inducing butyrate synthesis

In addition to the above technology, a novel pipeline capable of degrading TMA, a risk factor for cardiovascular disease, is under development by BioMe Inc.

Beyond discovering useful strains, BioMe Inc. is building a microbiome-based system that selectively produces beneficial metabolites or degrades hazardous counterparts. This development strategy represented by “Molecule First” is implemented through the iBTSTM (integrated BioMe Technology for Screen) platform.

Recently, Kim Bu Seon, a former managing director of SK Bioscience, has been recruited to design target product profiles for candidate strains. Preclinical trials are scheduled to begin in the first half of 2022, and clinical trials will begin in 2023.

What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: BioMeKorean Startupmicrobiome treatmentYonsei Medical Center
Previous Post

Korea’s Green New Deal 2022 to support 100 Korean startups for innovative green technology

Next Post

Korean startups: What to look forward to in 2022?

Next Post
Korean startups: What to look forward to in 2022?

Korean startups: What to look forward to in 2022?

0 0 votes
Article Rating
Subscribe
Login
Notify of
Please login to comment
0 Comments
Inline Feedbacks
View all comments
No Result
View All Result

Follow Us

FREE NEWSLETTER

Ecosystem Partners




PRODUCTS

Most Popular

  • 10 K-Dramas to watch for some ‘money matters’

    0 shares
    Share 0 Tweet 0
  • Top Korean Dating apps that can help you make new connections in South Korea

    1 shares
    Share 0 Tweet 0
  • Korean startups to showcase technological proficiency at CES 2023 from January 5 to 8 in Las Vegas 

    0 shares
    Share 0 Tweet 0
  • Korean hospitality tech startup Onda attracts over $9 million in investment

    0 shares
    Share 0 Tweet 0
  • Three Restaurant Apps to try out for a fine dining experience in South Korea  

    9 shares
    Share 9 Tweet 0
  • Korean webtoon ‘Lookism’ creator ‘The Grim Entertainment’ attracts $9.1 million investment

    0 shares
    Share 0 Tweet 0
  • Korean startups creating the K-Beauty buzz worldwide

    11 shares
    Share 11 Tweet 0
  • Seoul Robotics aims for an IPO in 2025, post-Series B funding of $ 25 million

    0 shares
    Share 0 Tweet 0
  • Korean Webtoon companies that are giving the audience addictive content

    15 shares
    Share 0 Tweet 0
  • Korean vegan food tech startup Join&Join shows 120% annual sales growth for brand Nuldam

    0 shares
    Share 0 Tweet 0
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KTO
    • KOTRA
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback

dgdfgfdgdf

What you think about Koreatechdesk, Share your idea with us!

feedback popup

Invitation submission has been closed

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.